What the FDA labels say about taking them together
Cimetidine and epirubicin
Epirubicin's FDA label of July 24, 2026 names cimetidine in its drug interactions section; the cimetidine label PlainMeds reads does not name epirubicin. The epirubicin label: “Cimetidine increases the exposure to epirubicin.”
Check it at the source: the cimetidine FDA label on DailyMed (effective July 15, 2026, Mylan Pharmaceuticals Inc.); the epirubicin FDA label on DailyMed (effective July 24, 2026, Pharmacia & Upjohn Company LLC).
What does the cimetidine label say about epirubicin?
Cimetidine's label (effective July 15, 2026) does not name epirubicin in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Cimetidine), Mylan Pharmaceuticals Inc., effective July 15, 2026 (SPL set 06c0a509-026f-44e0-9975-a94a8de51d43), via openFDA; the full label on DailyMed
What does the epirubicin label say about cimetidine?
Epirubicin label, drug interactionsCimetidine increases the exposure to epirubicin [see Clinical Pharmacology (12.3) ].
Source: FDA drug label (Ellence), NDA050778 (Pfizer Inc), as published by Pharmacia & Upjohn Company LLC, effective July 24, 2026 (SPL set 0a03c798-a652-4895-b29c-3b521a89ba42), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Cimetidine | Epirubicin | |
|---|---|---|
| Labeled for | Acid reflux and ulcers | n/a |
| Boxed warning | No | Yes |
| Pharmacy cost (NADAC) | $0.236 per tablet 300 mg tablet | n/a |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once